This article was originally published in The Tan Sheet
FDA challenges Iloveblow.com for marketing Blow energy drink mix as an alternative to an illicit street drug, according to a warning letter posted Feb. 26. FDA cites the product's name as well as marketing slogans and images posted on the firm's Web site, such as the name spelled out in a white granular substance, as evidence it is intended as a street drug alternative. Further, the product's marketing implies it is intended to affect the structure or function of the body, making the substance a drug, FDA says. Iloveblow.com had 15 days to respond to the warning letter, dated Jan. 31, outlining its steps to correct the cited violations. Failure to comply could lead to actions such as seizure or injunction, the agency notes. Blow's launch in 2007, like introductions of other products marketed with street drug references, immediately drew criticism from the Community Anti-Drugs Coalition of America (1"The Tan Sheet" Aug. 6, 2007, p. 10 and 2"The Tan Sheet" April 16, 2007, p. 13)...
You may also be interested in...
Three months after FDA acted on a trade group's complaint and took enforcement action against an energy beverage firm for marketing its product as an alternative to an illicit street drug, the dietary supplement industry has another opportunity to judge how well the agency responds to a firm using drug jargon to market a product
FDA's enforcement against Redux Beverages' unlawful claims for its Cocaine energy beverage is both welcome and long overdue, the Council for Responsible Nutrition says
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.